Abstract
Diabetic foot ulcers (DFUs) are common and constitute a considerable burden
for both patients and healthcare providers. Reducing the length of time to
healing reduces the risk of infection and further morbidity. Biofilms delay
healing, therefore, they should be treated with a biofilm-based wound care
regimen consisting of debridement, topical agents (antimicrobials and antiseptics)
and, if appropriate, systemic antibiotics (Cutting and Westgate, 2012). This
case series focuses on the use of octenilin®, which contains a broad-spectrum
antimicrobial, in the treatment of DFUs to address bioburden, prevent infection
and progress healing.
for both patients and healthcare providers. Reducing the length of time to
healing reduces the risk of infection and further morbidity. Biofilms delay
healing, therefore, they should be treated with a biofilm-based wound care
regimen consisting of debridement, topical agents (antimicrobials and antiseptics)
and, if appropriate, systemic antibiotics (Cutting and Westgate, 2012). This
case series focuses on the use of octenilin®, which contains a broad-spectrum
antimicrobial, in the treatment of DFUs to address bioburden, prevent infection
and progress healing.
| Original language | English |
|---|---|
| Pages (from-to) | 192-197 |
| Number of pages | 6 |
| Journal | The Diabetic Foot Journal |
| Volume | 21 |
| Issue number | 3 |
| Publication status | Published - 13 Sep 2018 |
